Abstract P2-01-16: Pharmacogenomic variants and risk of adverse events in breast cancer patients treated with Trastuzumab-deruxtecan: results from the PROCURE projectRodrigo Sánchez-Bayona, Cristina Rodríguez‐Antona, Juan Miguel Cejalvo et al.|Clinical Cancer Research|2025Cited by 3
8P Genomic variants associated with interstitial lung disease in patients treated with trastuzumab-deruxtecan: Results from the PROCURE projectRodrigo Sánchez-Bayona, Cristina Rodríguez‐Antona, Johny Nicolas et al.|ESMO Open|2025Cited by 0